Section divider

Since 1999, our goal in Bangladesh has been to protect women’s health.

  • With the Obstetrical and Gynecological Society of Bangladesh, Jhpiego introduced use of injectable magnesium sulfate for management of severe pre-eclampsia (a condition of pregnancy characterized by high blood pressure and protein in the urine) and eclampsia (the onset of seizures in a woman with severe pre-eclampsia). This lifesaving intervention has been rolled out to 140 health care facilities.
  • As a result of support under the MaMoni Health Services Strengthening project, 106 Union Health and Family Welfare Centers are now providing 24/7 delivery services in program areas (as compared to 11 at the beginning of the project)—thereby ensuring many more women deliver babies safely in health care facilities.
  • Jhpiego’s advocacy efforts resulted in a national policy—signed by the Directorate Generals of Health Services, Family Planning (FP) and Nursing and Midwifery—addressing district and upazila (subdistrict) health facility managers to ensure that all midwives in antenatal care units and labor rooms are offering FP services and have FP commodities and supplies available.

Our Work in Bangladesh

As a partner on this project, led by Save the Children and funded by the U.S. Agency for International Development, Jhpiego supports the overall objective of increasing equitable utilization of high-quality maternal and newborn care (MNC) services. This objective is being achieved by: 1) strengthening district-level capacity, 2) improving the quality of MNC services and quality-of-care governance, 3) improving access and demand for MNC services and household practices, and 4) improving the government of Bangladesh’s capacity to deliver high-quality MNC services at scale.

The purpose of this project is to improve maternal, newborn and child health outcomes through increased access to quality postpartum family planning (FP) services. With funding from UNFPA, Jhpiego is enhancing the capacity of six targeted upazilas within Cox’s Bazar District, to increase demand for, and supply of, FP information and services within integrated sexual and reproductive health care. The three overarching areas of focus are: 1) strengthening facilities to provide services; 2) building capacity of health care providers; and 3) creating demand for FP, with special attention on ensuring that counseling uses a rights-based approach and highlights the importance of women making choices best suited to their own needs and comfort. The project also supports implementation of a national FP program with quality service delivery of all FP methods at community, union, upazila and district levels in Cox’s Bazar. This includes tracking uninterrupted availability of supplies and commodities through an electronic logistics management information system and building the capacity of providers on FP clinical skills. To improve the quality of services in health facilities, this project promotes use of basic infection prevention measures and effective counseling in compliance with clinical standards. To identify eligible couples and promote FP use, the project uses mobilization of community-based skilled birth attendants, existing volunteers, community support groups and local government bodies, as well as establishing an effective referral system from community to the service delivery point with a sustainable mechanism for referral compliance tracking, monitoring and evaluation.

Funded by the Bill & Melinda Gates Foundation, this project is being implemented with Jhpiego as a sub-awardee to the International Vaccine Access Center (IVAC) of the Johns Hopkins Bloomberg School of Public Health. This three-year project is being implemented in Kenya and Bangladesh, with IVAC and Jhpiego working to develop project strategies, conduct research and facilitate in-country presence and expertise. In partnership with IVAC, Jhpiego is contributing to: 1) building capacity for maternal and newborn health outcome data collection in the context of COVID-19 infection; and 2) informing a pathway for inclusion of pregnant and lactating women, especially pregnant or lactating health care workers, in COVID-19 vaccination.


The Johns Hopkins Bloomberg School of Public Health’s International Vaccine Access Center and Jhpiego are conducting implementation research to inform the future delivery of new vaccines to pregnant and lactating women, specifically vaccines for respiratory syncytial virus (RSV) and Group B Strep (GBS). The goal of this project is to develop appropriate implementation recommendations, strategies and tools to ensure demand for new RSV and GBS vaccines among pregnant and lactating women in low- and middle-income countries, and to understand the potential impact of introducing a new maternal vaccine on antenatal care services, coverage, quality and equity.